Global Patent Index - EP 3768312 A4

EP 3768312 A4 20211117 - DETECTION OF INTERACTION BETWEEN AN ASSAY SUBSTANCE AND BLOOD OR BLOOD COMPONENTS FOR IMMUNE STATUS EVALUATION DISEASE DETECTION

Title (en)

DETECTION OF INTERACTION BETWEEN AN ASSAY SUBSTANCE AND BLOOD OR BLOOD COMPONENTS FOR IMMUNE STATUS EVALUATION DISEASE DETECTION

Title (de)

NACHWEIS EINER INTERAKTION ZWISCHEN EINER TESTSUBSTANZ UND BLUT ODER BLUTBESTANDTEILEN ZUR BEURTEILUNG DES IMMUNSTATUS ZUR KRANKHEITSERKENNUNG

Title (fr)

DÉTECTION D'UNE INTERACTION ENTRE UNE SUBSTANCE DE DOSAGE ET DU SANG OU DES COMPOSANTS SANGUINS POUR UNE DÉTECTION D'UNE MALADIE D'ÉVALUATION DE L'ÉTAT IMMUNITAIRE

Publication

EP 3768312 A4 20211117 (EN)

Application

EP 19771015 A 20190315

Priority

  • US 201862644467 P 20180317
  • US 2019022434 W 20190315

Abstract (en)

[origin: WO2019182885A1] Disclosed herein are unique assay methods and devices that provide simple and quick evaluation of function, status and/or activity of an immune system of a subject. Specifically exemplified is a method that involves mixing an assay substance with a blood or blood component from the subject to form an assay product that comprises at least one unit of the assay substance and at least one molecular component of the blood or blood component; analyzing the assay product under conditions to determine an assay product property (the assay product property including a physical, chemical, optical, electrical, magnetic, and/or mechanical property); and comparing the assay product property with a correlative property of an unexposed assay substance to generate a comparative data value, wherein the comparative data value indicates the function, status and/or activity of an immune system of the subject.

IPC 8 full level

A61K 39/395 (2006.01); C12Q 1/68 (2018.01); G01N 21/64 (2006.01); G01N 21/82 (2006.01); G01N 27/62 (2021.01); G01N 27/72 (2006.01)

CPC (source: EP US)

A61K 35/14 (2013.01 - US); A61K 39/395 (2013.01 - EP); B01L 3/021 (2013.01 - US); B01L 3/50825 (2013.01 - US); G01N 33/50 (2013.01 - EP); G01N 33/553 (2013.01 - US); G01N 33/554 (2013.01 - US); G01N 33/564 (2013.01 - US); G01N 2800/24 (2013.01 - EP US)

Citation (search report)

  • [X] US 2013058923 A1 20130307 - HUO QUN [US]
  • [X] ZHENG TIANYU ET AL: "A Rapid Blood Test To Determine the Active Status and Duration of Acute Viral Infection", ACS INFECTIOUS DISEASES, vol. 3, no. 11, 10 November 2017 (2017-11-10), US, pages 866 - 873, XP055848741, ISSN: 2373-8227, Retrieved from the Internet <URL:https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.7b00137> DOI: 10.1021/acsinfecdis.7b00137
  • [T] ZHENG TIANYU ET AL: "A Single-Step Gold Nanoparticle-Blood Serum Interaction Assay Reveals Humoral Immunity Development and Immune Status of Animals from Neonates to Adults", ACS INFECTIOUS DISEASES, vol. 5, no. 2, 8 February 2019 (2019-02-08), US, pages 228 - 238, XP055848679, ISSN: 2373-8227, Retrieved from the Internet <URL:https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.8b00213> DOI: 10.1021/acsinfecdis.8b00213
  • See references of WO 2019182885A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

WO 2019182885 A1 20190926; AU 2019239653 A1 20200924; CA 3092365 A1 20190926; CN 112189140 A 20210105; EP 3768312 A1 20210127; EP 3768312 A4 20211117; US 2021190781 A1 20210624

DOCDB simple family (application)

US 2019022434 W 20190315; AU 2019239653 A 20190315; CA 3092365 A 20190315; CN 201980033146 A 20190315; EP 19771015 A 20190315; US 201916981800 A 20190315